XOMA Royalty Corp 8-K

What Happened

• XOMA Royalty Corporation filed an 8‑K reporting the outcomes of its Annual Meeting held May 21, 2026 (record date March 25, 2026; 11,915,730 shares outstanding). All director nominees were elected and stockholders approved changes to the company’s equity plans and certain governance changes to the bylaws.
• The stockholders approved an amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan (increasing available shares by 425,000 and extending the plan term to March 16, 2036) and approved a new 2026 Employee Stock Purchase Plan (ESPP) providing 500,000 shares for issuance.
• The board also adopted bylaws amendments effective May 21, 2026 (in connection with the previously disclosed merger agreement with Ligand Pharmaceuticals), adding language regarding Nevada controlling interest statutes and an exclusive forum provision for certain corporate and federal securities claims.

Key Details

• Annual Meeting date: May 21, 2026; record date: March 25, 2026; shares outstanding: 11,915,730.
• LTIP amendment: +425,000 shares and term extended to March 16, 2036. (Filed as Exhibit 10.1.)
• ESPP approved: 500,000 shares available under the 2026 ESPP. (Filed as Exhibit 10.2.)
• Bylaws changes (effective May 21, 2026): references to Nevada controlling interest statutes (NRS 78.378–78.3793) and an exclusive forum clause (Eighth Judicial District Court of Clark County, Nevada for certain state claims; federal district courts for federal securities claims). (Filed as Exhibit 3.1.)
• Director election and vote totals (selected): all seven nominees elected. Examples — Owen Hughes: 8,339,874 for; Natasha Hernday: 8,301,769 for. Ratification of auditor (Deloitte & Touche LLP): 9,041,336 for, 12,019 against, 59,167 abstain.

Why It Matters

• Approving more equity for the LTIP and a 2026 ESPP gives the company flexibility to grant stock-based compensation and employee purchase rights, which can affect dilution and align employee incentives with shareholders.
• Bylaws amendments tied to Nevada statutes and an exclusive forum provision may affect where certain shareholder disputes are litigated and reflect governance adjustments related to the pending merger activity previously disclosed.
• Director re-elections and auditor ratification confirm continuity in board oversight and external audit arrangements—useful governance signals for investors assessing company stability during the merger process.